Trinity Biotech(TRIB)
Search documents
Trinity Biotech(TRIB) - 2018 Q4 - Annual Report
2019-05-14 15:54
SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT ...
Trinity Biotech(TRIB) - 2019 Q1 - Earnings Call Transcript
2019-05-11 21:41
Trinity Biotech PLC (NASDAQ:TRIB) Q1 2019 Earnings Conference Call May 7, 2019 11:00 AM ET Company Participants Joe Diaz - Lytham Partners Ronan O'Caoimh - CEO Kevin Tansley - CFO Conference Call Participants Jim Sidoti - Sidoti & Company Paul Nouri - Noble Equity Funds Operator Good morning, and welcome to the Trinity Biotech First Quarter 2019 Financial Results Conference Call. [Operator instructions] Please note this event is being recorded. I would now like to turn the conference over to Joe Diaz with L ...
Trinity Biotech (TRIB) Investor Presentation - Slideshow
2019-03-29 21:02
| --- | --- | |--------------------------------------|-------| | | | | POINT OF CARE \| CLINICAL LABORATORY | | | | | | | | | | | | | | | | | | | | | Your Diagnostics Partner | | | March 2019 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Nasdaq: TRIB | | Overview • Founded in 1992 – quoted on NASDAQ (TRIB) • Headquartered in Bray, Ireland (favourable tax regime – 12½% corporation tax) • Significant operations in the USA – direct salesforce; in addition to manufacturing operations in Buffalo, J ...
Trinity Biotech(TRIB) - 2018 Q4 - Earnings Call Transcript
2019-03-07 21:15
Trinity Biotech PLC (NASDAQ:TRIB) Q4 2018 Earnings Conference Call March 7, 2019 11:00 AM ET Company Participants Joe Diaz - Lytham Partners Kevin Tansley - CFO, Company Secretary & Executive Director Ronan O’Caoimh - Co-Founder, Chairman & CEO Conference Call Participants James Sidoti - Sidoti & Company Paul Nouri - Noble Equity Funds Operator Good day, and welcome to the Trinity Biotech Fourth Quarter and Fiscal Year 2018 Financial Results Conference Call. [Operator Instructions]. Please note, this event ...